Unigestion Holding’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,743
| Closed | -$1.12M | – | 189 |
|
|
2024
Q2 | $1.12M | Buy |
+2,743
| New | +$1.12M | 0.06% | 102 |
|
|
2024
Q1 | – | Sell |
-2,743
| Closed | -$1.12M | – | 159 |
|
|
2023
Q4 | $1.12M | Sell |
2,743
-72,806
| -96% | -$29.6M | 0.06% | 102 |
|
|
2023
Q3 | $26.6M | Buy |
75,549
+30
| +0% | +$10.6K | 1.63% | 22 |
|
|
2023
Q2 | $26.3M | Sell |
75,519
-29,652
| -28% | -$10.3M | 1.52% | 23 |
|
|
2023
Q1 | $32.8M | Sell |
105,171
-55
| -0.1% | -$17.2K | 1.78% | 18 |
|
|
2022
Q4 | $30.4M | Buy |
105,226
+8,161
| +8% | +$2.36M | 1.61% | 20 |
|
|
2022
Q3 | $28.4M | Buy |
97,065
+92,577
| +2,063% | +$27.1M | 1.65% | 19 |
|
|
2022
Q2 | $1.27M | Buy |
+4,488
| New | +$1.27M | 0.07% | 122 |
|
|
2020
Q4 | – | Sell |
-1,210
| Closed | -$329K | – | 250 |
|
|
2020
Q3 | $329K | Sell |
1,210
-1,095
| -48% | -$298K | 0.01% | 172 |
|
|
2020
Q2 | $670K | Buy |
+2,305
| New | +$670K | 0.02% | 143 |
|